Page 498 - Economia Azul - versão: inglês

management and marketing. Little is invest- ventures involved in biotechnology, although growth, and trends for the future. Informa- is analyzed based on the evaluation of the
ed by the entrepreneur, even in the initial there are companies operating in other tion is gathered on other available products technology used and its forms of production;
Despite the unfavorable facts, Brazilian . Bioenergy: development of new technolo- positioning (price, quality, or market niche), production of potential suppliers.
phase of the creation of the company. sub-areas: (competitors and substitutes), as well as their in addition to evaluating the technology and
sionals with high technical competence. . Environment: bioremediation, waste man- Business Planning, on the other hand, cor- that researchers in the Brazilian marine bio-
biotechnology companies have profes- gies for biofuels; their performance and the technologies used. However, another important aspect is

agement and recovery of devastated areas;
In companies with 1 to 10 employees,
approximately 40% have a PhD and 20% . Agriculture: biological pest control, responds to the planning of the sustainable technology area still face many difficulties
product and its commercialization model. It
in transforming their inventions into inno-
have a master’s degree. With good profes- biofertilizers, transgenic seeds and plant encompasses the definition of the strategy, vations, causing many inventions to end up
sionals being trained and attracted, it is ex- breeding; through activities to identify the stakehold- being published and then not progressing
pected that the result will be the contribu- . Animal health: animal breeding, phar- ers (interested parties) involved and potential to products.
tion of more investments, the adoption of maceuticals and vaccines, development of partners; product life cycle mapping; defini- The reason for this is the fact that ma-
tion of biotechnology in the Brazilian socio- . Reagents: enzymes, diagnostic kits, bio- for the production and commercialization the institutions that support the generation
stimulus policies and, finally, the consolida- technologies in animal reproduction; tion of the technical requirements necessary rine biotechnology researchers, as well as

economic development. It should be noted active molecules and antibodies; of the product; mapping the value chain of innovation in the Science and Technology
that although the researchers know very . Bioinformatics: analysis of diagnostic (macro-processes and production and com- Institutions (ICTs) in the country, are still un-
well the part of the technical development tests, sequencing, and consulting. mercialization processes); and identification able to meet the essential premises for the
of the products, they know little about the of differentials and critical success factors. It development of sustainable products in the
market in which they are inserted. This re- Companies in these areas are mainly also includes carrying out technical, econom- area. Thus, few products are effectively made
sults in additional difficulties in choosing concentrated in the Southeast region, with ic, environmental, and social feasibility stud- available to society, which reinforces the gap
strategies to leverage your products and/ São Paulo in first place with 18% of the ies. The technical feasibility of the product between innovation and development.
or your brand, and ultimately scaling your total number of companies, followed by 7. Development of Marine Biotechnology in Brazil
ventures to the market economy. Minas Gerais (13%), Rio de Janeiro (12%)
As previously mentioned, the area of hu- and Rio Grande do Sul (5%), in the south Marine Biotechnology has had an enor- for the sea in general. The Marine Biotech-

man health stands out for the number of of the country. mous growth in recent years in Brazil and in nology sector, due to its complexity and im-
the world. This fact is mainly related to prior- portance, should have its own public policy
6. Marine biotechnology and the development of new products
ities that the government has established for that could combine issues of the use of ma-
In order to arrive at a product in marine transfer structure, support institutions, re- the application of resources. However, there rine resources with environmental and legal
biotechnology, it is necessary that, in addi- search, and funding, as well as a whole legal is still a large space to be occupied by compa- issues. As it exists today, Marine Biotechnol-
tion to the knowledge derived from basic framework must be aligned. nies so that this growth can reach a level so ogy brings together decrees of law that are
research, there is a process of idea, discovery, Strategic market assessment is the process that the benefits for society are more visible. pulverized in the regulations of activities by
invention and production of the product for that encompasses the study of the product’s Public policies established by govern- regulatory agencies. These agencies have
its commercialization and availability to soci- market viability. In other words, it is the verifi- ments need to be reformulated in order to contributed to the strengthening of activities
ety, referring to a technological maturity scale cation of the commercialization feasibility of meet new national and international de- at sea, but they are not yet consolidated.
that takes an average of 10 years. the bioproduct, in which the market needs mands. Today, public policies for the sector There are legal obligations that these
This maturity scale, supported by Brazilian are detailed, identifying potential customers, are formulated within a tangle of laws and agencies have in acting in ST&I activities in
legislation, demonstrates that to be consid- competitors and the entire supply chain. In decrees that make it difficult to understand regulated sectors, relying on resources from
ered products, discoveries in marine biotech- addition, market demands are evaluated, and implement. Today, public policies for the the so-called RD&I clauses. These clauses are

nology need to be made available to society. that is, the quantities demanded of the prod- area of Marine Biotechnology in Brazil lack legal obligations of private investment in RD&I
And for this to happen, an entire technology uct, market growth in recent years, estimated greater specificity, as they were established defined by rules issued by the Regulatory

496 BLUE ECONOMY Development of Marine Biotechnology 497